Download PDF
Planta Med 1991; 57(6): 523-526
DOI: 10.1055/s-2006-960198
Papers

© Georg Thieme Verlag Stuttgart · New York

Anti-Hepatitic Activity of Ginesenoside Ro1

Hideaki Matsuda, Kei-ichi Samukawa, Michinori Kubo
  • Faculty of Pharmaceutical Sciences, Kinki University, 3-4-1, Kowakae, Higashiosaka, Osaka 577, Japan
1 Pharmacological Study on Panax ginseng C. A. Meyer; part XII. For part XI, see Matsuda, H., Samukawa, K., Kubo, M. (1990) Planta Med. 56, 19.
Further Information

Publication History

1990

Publication Date:
05 January 2007 (online)

  PDF Download  Permissions and Reprints

Abstract

Ginsenoside Ro, an oleanane-type saponin has been screened for activity in experimental models of acute and chronic hepatitis. Ginsenoside Ro (50 and 200 mg/kg, p.o.) inhibited the increase of serum glutamic oxaloacetic transaminase (s-GOT) and serum glutamic pyruvic transaminase (s-GPT) levels in D-galactosamine (GalN)- and carbon tetrachloride (CCl4)-induced acute hepatitic rats. Ginsenoside Ro inhibited the increase of connective tissue in the liver of CCl4-induced chronic hepatitic rats. Ginsenoside Ro showed a stronger inhibitory effect on the GalN-induced acute hepatitic model than those of the aglycone of ginsenoside Ro, oleanolic acid, or glycyrrhizic acid and its aglycone, glycyrrhetinic acid.

Key words

Panax ginseng - ginsenoside Ro - oleananetype saponin - D-galactosamine-induced hepatitis - carbon tetrachloride-induced hepatitis - connective tissue

      >